Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial | Stroke and Vascular Neurology

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Current issue

Archive

For authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

This article has a correction. Please see:

Correction: Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial - August 01, 2023

PDF +
Supplementary
Material

Protocol

Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial

Online download statistics by month:

Online download statistics by month: April 2022 to March 2024

	Abstract	Full	Pdf
Apr 2022	617	606	215
May 2022	248	242	72
Jun 2022	155	159	47
Jul 2022	104	102	45
Aug 2022	99	97	44
Sep 2022	69	65	48
Oct 2022	70	71	48
Nov 2022	0	0	44
Dec 2022	0	0	30
Jan 2023	1	1	11
Feb 2023	50	53	52
Mar 2023	123	112	69
Apr 2023	84	83	80
May 2023	99	94	69
Jun 2023	101	101	56
Jul 2023	107	107	71
Aug 2023	102	101	57
Sep 2023	98	95	64
Oct 2023	83	81	44
Nov 2023	116	115	71
Dec 2023	87	87	37
Jan 2024	68	55	43
Feb 2024	75	75	41
Mar 2024	71	70	115
Total	2627	2572	1473